SHAREHOLDERS' DEFICIT |
9 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 | |||||||||||||
| SHAREHOLDERS' DEFICIT | |||||||||||||
| SHAREHOLDERS' DEFICIT | NOTE 7. SHAREHOLDERS’ DEFICIT As discussed in Note 1, on June 12, 2026, the Company issued an aggregate of 4,657,499 Class A ordinary shares to the Sponsor, upon the conversion of an equal number of Class B ordinary shares held by the Sponsor. The Class A Ordinary Shares issued in connection with the Conversion are subject to the same restrictions applicable to the Class B Ordinary Shares prior to the Conversion, including certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination, as described in the final prospectus filed with the SEC by the Company on December 23, 2024 in connection with the Company’s Initial Public Offering. Preference shares — The Company is authorized to issue 1,000,000 preference shares, with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2026 and December 31, 2025, there were no preference shares issued or outstanding. Class A ordinary shares — The Company is authorized to issue 100,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of September 30, 2026 and December 31, 2025, there were 4,657,499 and 0 Class A ordinary shares issued and outstanding, excluding 14,651,303 and 17,250,000 Class A ordinary shares subject to possible redemption, respectively. Class B ordinary shares — The Company is authorized to issue 10,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to one vote for each share. As of September 30, 2026 and December 31, 2025, there were 1 and 4,657,500 Class B ordinary shares issued and outstanding, respectively. On all matters to be voted upon, except for (x) the appointment and removal of directors of the Board and (y) continuing the Company in a jurisdiction outside the Cayman Islands, holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class, unless otherwise required by applicable law. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of the initial Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 21.26% of the sum of the total number of all ordinary shares outstanding upon the completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination. Holders of Founder Shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment as provided above, at any time. Warrants — As of September 30, 2026 and December 31, 2025, there were 15,700,000 warrants outstanding, including 8,625,000 Public Warrants and 7,075,000 Private Placement Warrants. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the ordinary shares issuable upon exercise of the warrants and a current prospectus relating to such ordinary shares. Notwithstanding the foregoing, if a registration statement covering the ordinary shares issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00 per Class A ordinary share
The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon the exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. The exercise price and number of ordinary shares issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of ordinary shares at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Completion Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the Newly Issued Price, and the $18.00 share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. Subscription Agreement — As discussed in Note 1, on July 27, 2026, the Company and ProLogium entered into the Subscription Agreement with the Subscriber, pursuant to which the Subscriber agreed to purchase 5,000,000 Subscribed Shares at a purchase price of $10.00 per share, for an aggregate Purchase Price of $50,000,000, together with 5,000,000 Subscribed Warrants for no additional consideration. The Subscribed Warrants will have terms substantially identical to the Public Warrants, including an exercise price of $11.50 per share, except that they will not include any downward reset, ratchet, price protection or similar holder-favorable adjustment other than standard anti-dilution adjustments. The number of Subscribed Shares and Subscribed Warrants will be reduced, on a one-for-one basis, by any Class A ordinary shares held by the Subscriber that are designated as offset shares in accordance with the Subscription Agreement (the “Offset Shares”). Offset Shares consist of (i) Class A ordinary shares beneficially owned by the Subscriber as of the date of the Subscription Agreement and designated as Offset Shares on the Subscriber’s signature page to the Subscription Agreement and (ii) Class A ordinary shares purchased by the Subscriber in open market purchases or privately negotiated transactions after the date of the Subscription Agreement and prior to the record date for the extraordinary general meeting of shareholders to approve the Business Combination, at a price per share less than the per-share amount payable upon redemption of Class A ordinary shares in connection with such meeting, and designated by the Subscriber as Offset Shares. In order to constitute Offset Shares, such shares may not be transferred prior to the consummation of the Business Combination and the Subscriber may not exercise redemption rights with respect to such shares, and, with respect to shares described in clause (ii), the Subscriber may not vote such shares in favor of the Business Combination and must instead submit a proxy abstaining from voting thereon. As of the date of the Subscription Agreement, the Subscriber had not designated any Class A ordinary shares as Offset Shares. The Purchase Price is to be funded business days prior to the expected closing date of the Business Combination and held by the Company in escrow until the closing of the Business Combination. If the Business Combination is not consummated within business days after the expected closing date (or such later date as may be specified in a revised closing notice), the Company will return the Purchase Price to the Subscriber and any Subscribed Securities that have been issued will be cancelled. Unless the Subscription Agreement has been terminated, the Subscriber remains obligated to redeliver the Purchase Price upon receipt of a new closing notice and to consummate the subscription upon satisfaction of the applicable closing conditions. Until the Subscription Closing, the Company and ProLogium may not enter into, amend, modify or waive any other subscription agreement for the purchase of Class A ordinary shares in connection with the Business Combination in a manner that would provide another subscriber a purchase price per share less than $10.00 or other terms that, taken as a whole, are more favorable in any material respect than those of the Subscription Agreement, unless the Subscriber is offered the benefit of such lower price or more favorable terms on substantially the same basis. The Subscription Agreement will terminate upon the earliest to occur of (i) the valid termination of the Business Combination Agreement in accordance with its terms, (ii) the mutual written agreement of the parties to the Subscription Agreement and (iii) 30 days after the termination date specified in the Business Combination Agreement, if the closing has not occurred by such date other than as a result of a breach by the Subscriber, in which case any Purchase Price paid by the Subscriber will be returned to the Subscriber. The Company determined that the Subscription Agreement is a freestanding forward contract to issue Subscribed Shares and Subscribed Warrants. Under the Subscription Agreement, the Subscribed Securities are issued at the Subscription Closing while the Purchase Price is held by the Company in escrow and, if the Business Combination is not consummated within the period specified in the Subscription Agreement, the Company must return the Purchase Price and the Subscribed Securities are cancelled. Because the Subscription Agreement may require the Company to transfer cash in exchange for its shares upon an event outside its control, it is classified as a liability under ASC 480-10-25-8 and is not within the scope of ASC 815-40. In addition, because the number of Subscribed Securities may be reduced by Offset Shares, the Subscription Agreement would not be considered indexed to the Company’s own shares under ASC 815-40 (see Note 2). The Subscription Agreement was initially measured at its fair value of $11,000,000 on the date it was entered into, which was recognized as a loss on issuance of Subscription Agreement in the condensed statements of operations because no consideration was received, and subsequently remeasured to fair value at the reporting date. As of September 30, 2026, the Purchase Price had not been funded and no Subscribed Shares or Subscribed Warrants had been issued. The issuance of the Subscribed Securities at the Subscription Closing will be an issuance of Class A ordinary shares and equity-linked securities for capital raising purposes in connection with the closing of a Business Combination. Whether such issuance results in an adjustment to the exercise price of the warrants and the $18.00 share redemption trigger price as described above will depend on the Newly Issued Price of the Subscribed Shares, as determined in good faith by the Company’s board of directors, the proportion of the total equity proceeds available for the funding of the Business Combination (net of redemptions) represented by the Purchase Price, and the Market Value, and cannot be determined until the consummation of the Business Combination. As of September 30, 2026, no such adjustment had been triggered. If an adjustment is triggered, the value of its effect will be recognized as a deemed dividend and a reduction of income available to ordinary shareholders in the period in which it is triggered. |